Clinical trials: Best Disease
Coronavirus Disease 2019 Infectious Disease (COVID-19 Infection)
Amotosalen-Ultraviolet A Pathogen-Inactivated Convalescent Plasma in Addition to Best Supportive Care and Antiviral Therapy on Clinical Deterioration in Adults Presenting With Moderate to Severe COVID-19
This project investigates individual treatments using convalescent severe acute respiratory Syndrome Coronavirus 2 (SARS-CoV-2) plasma in SARS-CoV-2 infected patients at risk for disease progression.
- Trial name
- NCT04389944
- Testing
- convalescent plasma application to SARS-CoV-2 infected patients
- Where
- Switzerland
- Volunteers
- 15 people, healthy volunteers welcome
- Sponsor
- University Hospital, Basel, Switzerland
Metastatic Prostate Cancer
177Lu-DOTA-TLX591 Safety, Biodistribution and Dosimetry Study
This is a Phase 1 trial of TLX591, a monoclonal antibody HuX591 conjugated with a DOTA chelator and radiolabelled with 177Lu (177Lu-DOTA-TLX591).
- Trial name
- ProstACTSelect (NCT04786847)
- Testing
- 177Lu-DOTA-TLX591
- Where
- 3 sites in Australia
- Volunteers
- 30 people
- Sponsor
- Telix Pharmaceuticals (Innovations) Pty Limited
Aortic Valve Stenosis
Balloon-Expandable Versus Self-expanding Transcatheter Heart Valve for Treatment of Symptomatic Native Aortic Valve Stenosis (BEST)
Over the last years, several randomized studies comparing transcatheter aortic valve implantation (TAVI) to surgical aortic valve replacement (SAVR) have established TAVI as a treatment option in symptomatic patients with aortic…
- Trial name
- BEST (NCT05454150)
- Testing
- balloon-expandable valve, self-expanding valve
- Where
- 21 sites in France
- Volunteers
- 1,960 people
- Sponsor
- University Hospital, Lille
Asthma
Mannitol Bronchoprovocation Challenge Ancillary Study/ACRN
This is an ancillary study conducted as part of the BASALT trial [NCT00495157]. The overall hypotheses are: 1) an indirect airway challenge procedure using mannitol can safely characterize asthma phenotypes, predict asthma…
- Trial name
- NCT00585260
- Testing
- mannitol
- Where
- United States
- Volunteers
- 66 people
- Sponsor
- University of Wisconsin, Madison
Infertility
Clinical Outcomes of Slow Developing Blastocysts
This study evaluates which transfer strategy will result in a higher probability of pregnancy in patients whose single best day 5 embryo resulting from an IVF cycle is classified as expansion grade <4 by Gardner and Schoolcraft…
- Trial name
- LATEBLOOM (NCT03360097)
- Testing
- Frozen Embryo Transfer
- Where
- Spain
- Volunteers
- 2 people, healthy volunteers welcome
- Sponsor
- Fundacion Dexeus
Multiple Myeloma
A Comparative Clinical Study to Determine the Optimal Initial Therapy for Multiple Myeloma
This study evaluates the outcomes of patients undergoing initial therapy for multiple myeloma.
- Trial name
- NCT06151717
- Testing
- Non-Interventional Study
- Where
- 4 sites in United States
- Volunteers
- 50 people
- Sponsor
- Mayo Clinic
Carotid Stenosis
Determination of the Best Therapeutic Strategy, Interventional With Best Medical Management (BMM) Versus BMM Alone, for Patients With Symptomatic Moderate <70% Atherosclerotic Carotid Artery Stenosis: the SIMCA Multicenter Randomized Trial
Stroke is one of the leading causes of death and the main cause of long-term disability worldwide. A frequent cause is the narrowing of the carotid artery due to atherosclerosis, known as carotid artery stenosis.
- Trial name
- SIMCA (NCT07839390)
- Testing
- endarterectomy, stenting, Control group
- Volunteers
- 1,440 people
- Sponsor
- Central Hospital, Nancy, France
Macular Degeneration, Geographic Atrophy
A Prospective Observational Study to Assess the Reliability and Validity of the MLSDT
The goal of this observational study is to assess the reliability and validity of the 9-object MLSDT for evaluation of participants with moderate to severe vision impairment when tested without a wearable low-vision magnifying…
- Conditions
- Macular Degeneration, Geographic Atrophy, Stargardt Disease
- Trial name
- NCT06805474
- Testing
- Observational
- Where
- United States
- Volunteers
- 30 people, healthy volunteers welcome
- Sponsor
- Nanoscope Therapeutics Inc.
Colorectal Cancer
Phase II Study of Avastin + Erbitux + Irinotecan as 2nd Line Treatment of Colorectal Cancer
This phase II study will evaluate the efficacy of the combination of two monoclonal antibodies (Avastin + Erbitux) with irinotecan, in patients with colorectal cancer progressed after 1st line treatment with FOLFIRI Avastin or…
- Trial name
- NCT00681876
- Testing
- Irinotecan, Avastin, Erbitux
- Where
- 8 sites in Greece
- Volunteers
- 16 people
- Sponsor
- Hellenic Oncology Research Group
Pancreatic Cancer
Comparing Parenteral Nutrition vs Best Supportive Nutritional Care in Patients With Pancreatic Cancer
A randomised multicentre clinical phase IIIb trial for patients suffering from pancreatic adenocarcinoma receiving defined second or higher line chemotherapy and additionally parenteral nutrition (study arm A) or best supportive…
- Trial name
- PANUSCO (NCT01362582)
- Testing
- SMOF Kabiven
- Where
- 4 sites in Germany
- Volunteers
- 32 people
- Sponsor
- National Center for Tumor Diseases, Heidelberg
Bone Diseases, Communication
Evaluation of Alerts in Promoting Bone Densitometry Scans
The purpose of this study is to assess, prospectively, the effect of provider-facing alerts for bone densitometry scans with and without a single-click best practice alert (BPA) on scan orders and completions.
- Trial name
- NCT04955652
- Testing
- Health Maintenance Topic, Actionable Sidebar Item, Best Practice Alert
- Volunteers
- healthy volunteers welcome
- Sponsor
- Geisinger Clinic
Intracranial Aneurysm
Flow Diversion in Intracranial Aneurysm Treatment
Flow diverters are a recent addition to the range of endovascular devices now available for the treatment of intracranial aneurysms.
- Trial name
- FIAT (NCT01349582)
- Testing
- flow diversion, conservative management, endovascular coiling
- Where
- 3 sites in Canada
- Volunteers
- 323 people
- Sponsor
- Centre hospitalier de l'Université de Montréal (CHUM)
COVID-19
Geriatric Population COVID-19 Observational Study (GEROCOVIDobs)
The GeroCovid e-Registry is a European de-identified clinical data electronic registry of geriatric patients at risk or suffering from COVID-19 (suspected and confirmed cases) observed since 1st March 2020 in the participating…
- Trial name
- GEROCOVIDobs (NCT04379440)
- Where
- 7 sites in Italy
- Volunteers
- 1,500 people
- Sponsor
- Raffaele Antonelli Incalzi
Obesity in Pregnancy
Best Start - Weight Management During Pregnancy
The investigators know that being overweight during pregnancy increases the health risks to both mum and baby. There is good evidence that diet or exercise, or both, during pregnancy can reduce excessive weight gain.
- Trial name
- NCT03875300
- Testing
- Foodwise in Pregnancy
- Where
- 4 sites in United Kingdom
- Volunteers
- 526 people, healthy volunteers welcome
- Sponsor
- Cwm Taf University Health Board (NHS)
Leukemia, Myeloid, Acute
Efficacy of Oral Azacitidine Plus Best Supportive Care as Maintenance Therapy in Subjects With Acute Myeloid Leukemia (AML) in Complete Remission
This study enrolled 472 participants, aged 55 or older, with a diagnosis of de novo acute myeloid leukemia (AML) or AML secondary to prior myelodysplastic disease or chronic myelomonocytic leukemia (CMML), and who have achieved…
- Trial name
- QUAZAR AML-001 (NCT01757535)
- Testing
- Oral Azacitidine
- Where
- 223 sites in United States, Australia and 21 more
- Volunteers
- 472 people
- Sponsor
- Celgene
Thoracoabdominal Aortic Aneurysms
CUstodiol Versus RInger: whaT Is the Best Agent?
Postoperative renal failure is the most significant risk factor for early mortality after elective surgical repair of thoracoabdominal aortic aneurysms (TAAAs).
- Trial name
- NCT02327611
- Testing
- Custodiol, Enriched Ringer's lactate solution
- Where
- Italy
- Volunteers
- 90 people
- Sponsor
- Scientific Institute San Raffaele
Stomach Cancer, Esophageal Cancer
Comparison of Standard of Care or Treatment on Protocol
Patient will choose to either receive the standard of care according to National Comprehensive Cancer Network (NCCN) or approved guidelines for their condition or to be treated according to one arm of the protocol that they could…
- Conditions
- Stomach Cancer, Esophageal Cancer, Bladder Cancer, Skin Cancer
- Trial name
- NCT01010334
- Testing
- standard of care
- Where
- United States
- Volunteers
- 13 people
- Sponsor
- New Mexico Cancer Research Alliance
Obsessive-Compulsive Disorder
European Study of Quality of Life in Resistant OCD Patients Treated by STN DBS
Obsessive-Compulsive Disorder (OCD) is among the most disabling psychiatric disorders as more than 40% of patients are resistant to the standard pharmacological and psychotherapy approaches and about 10% show severe disability…
- Trial name
- EQOLOC (NCT02844049)
- Testing
- Deep Brain Stimulation
- Where
- 8 sites in France, Germany and 2 more
- Volunteers
- 60 people
- Sponsor
- University Hospital, Grenoble
Glioblastoma Multiforme, Glioblastoma
Efficacy and Safety of NaviFUS System add-on Bevacizumab (BEV) in Recurrent GBM Patients
This is a prospective, single-arm, two stages, open-label, pilot study to investigate the efficacy and safety of FUS add-on bevacizumab (BEV) in rGBM patients.
- Conditions
- Glioblastoma Multiforme, Glioblastoma, Glioma, Brain Tumor
- Trial name
- NCT04446416
- Testing
- NaviFUS System, Bevacizumab
- Where
- Taiwan
- Volunteers
- 6 people
- Sponsor
- NaviFUS Corporation
Asthma
MONO: Symbicort® Single Inhaler Therapy and Conventional Best Standard Treatment for the Treatment of Persistent Asthma in Adolescents and Adults
The purpose of the study is to compare the efficacy of a flexible dose of Symbicort (budesonide/formoterol) with conventional stepwise best standard treatment in patients with persistent asthma.
- Trial name
- NCT00242411
- Testing
- Budesonide/Formoterol Turbuhaler, Conventional Best Asthma Therapy
- Where
- 179 sites in Denmark, Finland and 1 more
- Volunteers
- 1,900 people
- Sponsor
- AstraZeneca